Insider Stock Trading History of Robertson Sanford


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Robertson Sanford since year 2005. The trader's CIK number is 1250105. At the time of this reporting, Robertson Sanford is the Director of Dolby Laboratories, Inc. . (stock ticker symbol DLB). See this page for all insider trading activities at Dolby Laboratories, Inc. .

Note that in the past ROBERTSON SANFORD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Robertson Sanford since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-07-30 DLB Dolby Laboratories, Inc. Sale 36,935 45.01 1,662,407
2014-07-31 DLB Dolby Laboratories, Inc. Sale 25,059 44.71 1,120,337
2014-07-31 DLB Dolby Laboratories, Inc. Option Ex 25,059 22.62 566,759
2014-03-21 PTIE Pain Therapeutics Inc Option Ex 68,635 4.59 315,034
2013-11-06 PTIE Pain Therapeutics Inc Buy 31,838 3.76 119,710
2013-11-04 PTIE Pain Therapeutics Inc Buy 18,162 3.69 67,017
2013-08-02 RPXC Rpx Corp Buy 10,000 16.65 166,490
2013-05-08 CRM Salesforce Com Inc Option Ex 160,000 1.00 160,000
2013-05-01 PTIE Pain Therapeutics Inc Option Ex 42,897 4.10 175,877
2013-02-27 RPXC Rpx Corp Buy 50,000 12.84 641,750
2012-12-14 CRM Salesforce Com Inc Option Ex 17,767 4.00 71,068
2012-12-17 CRM Salesforce Com Inc Sale 22,233 166.75 3,707,441
2012-12-17 CRM Salesforce Com Inc Option Ex 22,233 4.00 88,932
2012-12-14 CRM Salesforce Com Inc Sale 17,767 166.92 2,965,649
2012-12-05 CRM Salesforce Com Inc Sale 800 155.90 124,720
2012-09-13 CRM Salesforce Com Inc Sale 10,000 154.18 1,541,790
2011-11-10 RPXC Rpx Corp Buy 28,676 14.03 402,324
2011-11-11 RPXC Rpx Corp Buy 21,324 14.33 305,572
2011-05-12 DLB Dolby Laboratories, Inc. Sale 10,000 49.88 498,780
2010-12-09 CRM Salesforce Com Inc Option Ex 20,000 4.00 80,000
2010-12-09 CRM Salesforce Com Inc Sale 20,000 149.69 2,993,780
2010-06-11 CRM Salesforce Com Inc Sale 3,000 93.46 280,374
2009-12-01 CRM Salesforce Com Inc Sale 1,500 62.91 94,365
2010-05-04 DLB Dolby Laboratories, Inc. Sale 9,999 67.50 674,932
2010-03-22 CRM Salesforce Com Inc Option Ex 50,000 4.00 200,000
2010-03-22 CRM Salesforce Com Inc Sale 50,000 74.59 3,729,500
2009-10-15 PTIE Pain Therapeutics Inc Buy 50,000 2.00 100,000
2009-09-11 CRM Salesforce Com Inc Option Ex 50,000 4.00 200,000
2009-09-11 CRM Salesforce Com Inc Sale 50,000 58.03 2,901,600
2009-09-02 CRM Salesforce Com Inc Sale 1,500 51.50 77,250
2009-06-09 CRM Salesforce Com Inc Sale 11,500 39.82 457,964
2009-03-04 PTIE Pain Therapeutics Inc Buy 25,000 .10 2,500
2007-12-21 CRM Salesforce Com Inc Option Ex 100,000 4.00 400,000
2007-12-21 CRM Salesforce Com Inc Sale 100,000 63.67 6,366,700
2007-11-14 DLB Dolby Laboratories, Inc. Sale 5,100 49.46 252,266
2007-11-14 DLB Dolby Laboratories, Inc. Sale 14,899 48.63 724,597
2007-11-13 DLB Dolby Laboratories, Inc. Sale 10,300 48.85 503,185
2007-11-13 DLB Dolby Laboratories, Inc. Sale 9,700 49.31 478,326
2006-11-17 DLB Dolby Laboratories, Inc. Sale 7,500 28.56 214,192
2006-11-17 DLB Dolby Laboratories, Inc. Sale 2,500 28.84 72,087
2006-11-16 DLB Dolby Laboratories, Inc. Sale 4,700 28.89 135,773
2006-11-15 DLB Dolby Laboratories, Inc. Sale 8,800 28.61 251,741
2006-11-15 DLB Dolby Laboratories, Inc. Sale 1,200 28.89 34,664
2006-11-16 DLB Dolby Laboratories, Inc. Sale 5,300 29.22 154,850
2006-08-10 DLB Dolby Laboratories, Inc. Sale 10,000 18.05 180,500
2006-08-10 DLB Dolby Laboratories, Inc. Sale 10,000 18.05 180,500
2006-08-09 DLB Dolby Laboratories, Inc. Sale 10,000 18.54 185,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robertson Sanford (Director of Dolby Laboratories, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.